Phase 1 Clinical Trial of CUDC-101 “Throws Kitchen Sink” at Head and Neck Cancer
January 26, 2015 · Comments Off on Phase 1 Clinical Trial of CUDC-101 “Throws Kitchen Sink” at Head and Neck Cancer
Clinical Trial of CUCD-101 shows activity against drivers of head and neck cancer, EGFR, Her2 and HDAC
Medical oncology faculty promotions 2014
July 1, 2014 · Comments Off on Medical oncology faculty promotions 2014
Four University of Colorado Cancer Center investigators and Department of Medical Oncology faculty were recently...
Results in Phase I Trial of OMP-54F28, a Wnt Inhibitor Targeting Cancer Stem Cells
May 31, 2014 · Comments Off on Results in Phase I Trial of OMP-54F28, a Wnt Inhibitor Targeting Cancer Stem Cells
Phase 1 clinical trial results presented at ASCO 2014 pave way for cancer stem cell drug, OMP-54F28, in new clinical trials for pancreatic, ovarian, and hepatocellular cancers.
AACR News: Rigosertib Phase 1 results lead to disease-focused Phase 2 development
April 9, 2013 · Comments Off on AACR News: Rigosertib Phase 1 results lead to disease-focused Phase 2 development
Results of a phase 1 clinical trial reported at the American Association for Cancer Research (AACR) annual conference show that orally administered Rigosertib is well tolerated in patients with advanced solid tumors. This is the first trial in which orally administered Rigosertib, a dual kinase inhibitor, was studied in solid tumors. Intravenously rigosertib is already in phase 3 clinical trials for myelodysplastic syndrome and pancreatic cancer and oral rigosertib is being studied in a pair of Phase II trials in lower-risk transfusion dependent MDS patients. The drug candidate is being developed by Onconova Therapeutics, Inc., of Pennington, NJ.
That dude is tough as nails
May 30, 2012 · Comments Off on That dude is tough as nails
No sore throat should last a year and a half. Tim Elliott tried antibiotics and...
“It’s now a part of our family history”
April 23, 2012 · Comments Off on “It’s now a part of our family history”
Blindsided by multiple cancer diagnoses in one year, family and friends decide to do something...
A five-year dispute over Gardasil, a vaccine that protects against human papillomavirus (HPV), just got...
NIH funds first cancer stem cell clinical trial at University of Colorado Cancer Center
September 19, 2011 · Comments Off on NIH funds first cancer stem cell clinical trial at University of Colorado Cancer Center
The National Institute of Health recently awarded University of Colorado Cancer Center investigator Antonio Jimeno...
Phase I trial of promising anti-cancer drug CUDC-101 opens with first patient treated at CU Cancer Center
August 18, 2011 · Comments Off on Phase I trial of promising anti-cancer drug CUDC-101 opens with first patient treated at CU Cancer Center
The University of Colorado Cancer Center has treated the first patient with a promising cancer-fighting...
Dietary supplements shown to increase cancer risk
August 18, 2011
AACR amc cancer fund American Association for Cancer Research andrew thorburn anthony elias antonio jimeno ASCO biomarkers bladder cancer breast cancer cancer cancer grants cancer prevention cancer research colorado Cancer Survivorship clinical trial colon cancer colorado cancer benefit colorectal cancer crizotinib CU Cancer Center Dan Theodorescu fred hirsch funding opportunity grant head-and-neck cancer james degregori jennifer richer leukemia lung cancer lung cancer research melanoma ovarian cancer Pancreatic cancer paul bunn prostate cancer publications rajesh agarwal ross camidge skin cancer tim byers university of colorado cancer center university of colorado hospital university of colorado school of medicine wells messersmith
We will be at this year's ASCO! twitter.com/rsm2800/status…
Did you know only 2-3% of funding is dedicated to metastatic breast cancer research? METAvivor wants to change that..ow.ly/NcpKE